Cargando…
The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinoma
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers globally, with a poor prognosis and ambiguous therapy target. As a hallmark of cancer, metabolism reprogramming plays a critical role in the development of ESCC; however, the genomic alterations underlying this r...
Autores principales: | Liu, Xuesong, Hong, Ruoxi, Du, Peina, Yang, Di, He, Meibo, Wu, Qingnan, Li, Lin, Wang, Yan, Chen, Jie, Min, Qingjie, Li, Jinting, Zhang, Weimin, Zhan, Qimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475459/ https://www.ncbi.nlm.nih.gov/pubmed/36168622 http://dx.doi.org/10.7150/thno.70814 |
Ejemplares similares
-
MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma
por: Wu, Qingnan, et al.
Publicado: (2021) -
The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma
por: Wu, Qingnan, et al.
Publicado: (2022) -
Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma
por: Min, Qingjie, et al.
Publicado: (2021) -
Defect of SLC38A3 promotes epithelial-mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma
por: Liu, Rui, et al.
Publicado: (2020) -
Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
por: Li, Xianfeng, et al.
Publicado: (2023)